申请人:Henan Genuine Biotech Co., Ltd.
公开号:EP3845524A1
公开(公告)日:2021-07-07
The present invention belongs to the field of medicinal chemistry, relates to novel benzoic acid compounds I and II, and relates to the applications thereof in prevention and treatment or remission of cerebral ischemia or ischemia after acute and chronic myocardial infarction. In the structures of compounds I and II, X is H, I, Br, Cl, F, CN, amino and derivatives thereof. R1 is the alkyl of C2-10, which is substituted for C2-10 alkyl, except for N-butane; M is an organic amine ion or a metal ion.
本发明属于药物化学领域,涉及新型苯甲酸化合物I和II,并涉及其在预防和治疗或缓解脑缺血或急慢性心肌梗塞后缺血中的应用。在化合物 I 和 II 的结构中,X 是 H、I、Br、Cl、F、CN、氨基及其衍生物。R1是C2-10的烷基,除N-丁烷外,C2-10的烷基被取代;M是有机胺离子或金属离子。